<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="the effect of interferons (Table 1). For a long time," exact="rimantadine" post="and amantadine were very actively used to treat the"/>
 <result pre="of interferons (Table 1). For a long time, rimantadine and" exact="amantadine" post="were very actively used to treat the flu. Leibbrand"/>
 <result pre="the virus particle to the cytoplasm of the cell. Thus," exact="rimantadine" post="becomes an obstacle between the influenza virus and the"/>
 <result pre="undecivir/RelenzaTM), M2 channel blockers, and fusion inhibitors (umifenovir/ArbidolTM). Zanamivir and" exact="oseltamivir" post="have shown lower than expected efficacy in clinical trials."/>
 <result pre="factors [41]. According to the literature, sulphated polysaccharides (fucoidans, galactofucans," exact="dextran" post="sulphates, carrageenans, sulphated chitosans, synthetic polyvinyl, and polyethylene sulphates)"/>
 <result pre="other drugs. Thus, a combined intranasal spray, including carrageenan and" exact="zanamivir" post="(an NA inhibitor) was proposed by Morokutti-Kurz et al."/>
 <result pre="efficacy of in vivo and in vitro intranasal administration of" exact="zanamivir" post="in different doses for the prevention and treatment of"/>
 <result pre="complex preparation were non-toxic at the highest concentration (400 μg/mL" exact="zanamivir" post="and 533 μg/mL carrageenan). The effectiveness of the suppression"/>
 <result pre="substances depended on the virus strain. The IC50 value for" exact="zanamivir" post="ranged from 0.18 µg/mL for H5N1 and 22.97 µg/mL"/>
 <result pre="µg/mL to 118.40 µg/mL for H1N1 and H7N7, respectively. Thus," exact="zanamivir" post="and carrageenan target different strains of influenza virus to"/>
 <result pre="two drugs was suggested [69]. For more than 50 years," exact="xylometazoline" post="has been used to relieve vasoconstriction and oedema of"/>
 <result pre="treated with fucoidan. The authors proposed the combined treatment with" exact="oseltamivir" post="and fucoidan, because in this case there was no"/>
 <result pre="when treating only with oseltamivir. Combined treatment with fucoidan and" exact="oseltamivir" post="was thus recommended by the authors as a new"/>
 <result pre="to the control group (p &amp;lt; 0.05). When treated with" exact="oseltamivir" post="alone, 90% of the mice survived. All influenza viruses"/>
 <result pre="Infection, From Now and Into the FutureFront. Immunol.20189194610.3389/fimmu.2018.0194630250466 36.MartyF.M.Vidal-PuigserverJ.ClarkC.GuptaS.K.MerinoE.GarotD.ChapmanM.J.JacobsF.Rodriguez-NoriegaE.HusaP.et al.Intravenous" exact="zanamivir" post="or oral oseltamivir for hospitalised patients with influenza: An"/>
 <result pre="and Into the FutureFront. Immunol.20189194610.3389/fimmu.2018.0194630250466 36.MartyF.M.Vidal-PuigserverJ.ClarkC.GuptaS.K.MerinoE.GarotD.ChapmanM.J.JacobsF.Rodriguez-NoriegaE.HusaP.et al.Intravenous zanamivir or oral" exact="oseltamivir" post="for hospitalised patients with influenza: An international, randomised, double-blind,"/>
 <result pre="the Murine ModelPLoS ONE201510e012879410.1371/journal.pone.012879426053018 69.GrafC.Bernkop-SchnurchA.EqyedA.CollerC.Prieschl-GrassauerA.Morokutti-KurzM.Development of a nasal spray containing" exact="xylometazoline" post="hydrochloride and iota-carrageenan for the symptomatic relief of nasal"/>
 <result pre="(nausea and vomiting; diarrhea, abdominal bloating, and fecal incontinence) Rimantadine," exact="amantadine" post="M2 channel blockers. An inhibitor of the early stage"/>
</results>
